DUMMY

Portfolio Holdings Listing

Select Health Care Portfolio
as of December 31, 2014

The portfolio holdings listing (listing) provides information on a funds investments as of

the date indicated. Top 10 holdings information (top 10 holdings) is also provided for
certain equity and high income funds. The listing and top 10 holdings are not part of a
funds annual/semiannual report or Form N-Q and have not been audited.
The information provided in this listing and top 10 holdings may differ from a funds
holdings disclosed in its annual/semiannual report and Form N-Q as follows, where
applicable:
With certain exceptions, the listing and top 10 holdings provide information on
the direct holdings of a fund as well as a funds pro rata share of any securities
and other investments held indirectly through investment in underlying nonmoney market Fidelity Central Funds. A funds pro rata share of the underlying
holdings of any investment in high income and floating rate central funds is
provided at a funds fiscal quarter end. For certain funds, direct holdings in high
income or convertible securities are presented at a funds fiscal quarter end and
are presented collectively for other periods.
For the annual/semiannual report, a funds investments include trades executed
through the end of the last business day of the period. This listing and the top 10
holdings include trades executed through the end of the prior business day.
The listing includes any investment in derivative instruments, and excludes the
value of any cash collateral held for securities on loan and a funds net other
assets. Therefore, the holdings as a percent of fund net assets may not total to
100%.
The presentation of investment holdings by category is similar to that used in
other marketing materials.
The top 10 holdings is presented to illustrate examples of the securities that the fund has
bought and the diversity of the areas in which the fund may invest, may not be representative
of the funds current or future investments, and may change at any time. The top 10
holdings do not include cash, cash equivalents, money market instruments, options,
interest rate swaps, fixed income total return swaps and/or futures contracts. Depositary
receipts, credit default swaps and equity total return swaps are normally combined with
the underlying security.
The most recent annual/semiannual report can be viewed at www.fidelity.com or
www.advisor.fidelity.com. Forms N-Q are available on the SECs web site at www.sec.gov.
Before investing, consider the funds investment objectives, risks, charges and expenses.
Contact Fidelity for a prospectus containing this information. Read it carefully.

TOP TEN HOLDINGS

Security Name
Actavis PLC
Medtronic, Inc.
McKesson Corp.
Amgen, Inc.
Alexion Pharmaceuticals, Inc.
Celgene Corp.
Boston Scientific Corp.
Shire PLC sponsored ADR
Mallinckrodt PLC
Vertex Pharmaceuticals, Inc.

Market Value
$638,376,800
$469,300,000
$404,781,000
$382,296,000
$314,551,000
$310,970,800
$294,280,685
$272,051,200
$257,478,000
$244,728,000

% of Net
Assets
7.4%
5.5%
4.7%
4.4%
3.7%
3.6%
3.4%
3.2%
3.0%
2.8%

Top Ten Holdings Total:

$3,588,813,485

41.7%

Fidelity Distributors Corporation

82 Devonshire Street
Not Part of Annual or Semiannual Report

Boston, MA 02109

FULL HOLDINGS LISTING

Security Name
Domestic Equities

Market Value

% of Net
Assets

Medtronic, Inc.
McKesson Corp.
Amgen, Inc.
Alexion Pharmaceuticals, Inc.
Celgene Corp.
Boston Scientific Corp.
Vertex Pharmaceuticals, Inc.
Gilead Sciences, Inc.
Agilent Technologies, Inc.
Cerner Corp.
Puma Biotechnology, Inc.
Zimmer Holdings, Inc.
Danaher Corp.
Cardinal Health, Inc.
Allergan, Inc.
Thermo Fisher Scientific, Inc.
HCA Holdings, Inc.
Cigna Corp.
BioMarin Pharmaceutical, Inc.
Biogen Idec, Inc.
Edwards Lifesciences Corp.
athenahealth, Inc.
AbbVie, Inc.
Merck & Co., Inc.
Keysight Technologies, Inc.
Mylan, Inc.
Universal Health Services, Inc. Class B
Bristol-Myers Squibb Co.
Humana, Inc.
Prestige Brands Holdings, Inc.
The Cooper Companies, Inc.
Brookdale Senior Living, Inc.
ResMed, Inc.
Air Methods Corp.
HeartWare International, Inc.
Medidata Solutions, Inc.
Bruker BioSciences Corp.
Neurocrine Biosciences, Inc.
CONMED Corp.
NxStage Medical, Inc.
Illumina, Inc.
WageWorks, Inc.
Alnylam Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc.
Steris Corp.
UnitedHealth Group, Inc.
Vanda Pharmaceuticals, Inc.
PRA Health Sciences, Inc.
Surgical Care Affiliates, Inc.
Ultragenyx Pharmaceutical, Inc.

$469,300,000
$404,781,000
$382,296,000
$314,551,000
$310,970,800
$294,280,685
$244,728,000
$179,094,000
$175,223,200
$174,582,000
$158,986,800
$151,982,800
$137,136,000
$129,168,000
$106,295,000
$100,232,000
$93,939,200
$92,619,000
$90,400,000
$89,614,800
$89,166,000
$88,119,360
$83,763,200
$79,506,000
$79,360,648
$78,918,000
$77,882,000
$75,558,400
$71,815,000
$69,440,000
$64,836,000
$64,539,200
$61,666,000
$61,642,000
$55,709,872
$53,862,000
$44,733,600
$44,680,000
$41,812,800
$39,446,000
$38,761,800
$38,742,000
$36,840,600
$35,880,000
$35,667,500
$35,381,500
$35,084,000
$33,908,000
$33,650,000
$31,813,000

5.446%
4.697%
4.436%
3.650%
3.609%
3.415%
2.840%
2.078%
2.033%
2.026%
1.845%
1.764%
1.591%
1.499%
1.233%
1.163%
1.090%
1.075%
1.049%
1.040%
1.035%
1.023%
0.972%
0.923%
0.921%
0.916%
0.904%
0.877%
0.833%
0.806%
0.752%
0.749%
0.716%
0.715%
0.646%
0.625%
0.519%
0.518%
0.485%
0.458%
0.450%
0.450%
0.428%
0.416%
0.414%
0.411%
0.407%
0.393%
0.390%
0.369%

Fidelity Distributors Corporation

82 Devonshire Street
Not Part of Annual or Semiannual Report

Boston, MA 02109

Market Value
$31,062,000
$30,142,800
$29,975,264
$29,200,064
$27,020,500
$26,866,835
$23,608,200
$23,051,600
$23,039,440
$22,400,000
$21,945,105
$19,700,000
$19,684,000
$19,580,000
$18,375,000
$18,020,000
$17,807,500
$17,161,500
$17,024,000
$15,084,000
$14,435,862
$13,580,829
$13,534,500
$12,398,669
$12,381,185
$12,232,000
$11,352,000
$10,594,730
$9,310,000
$8,537,940
$8,188,775
$7,574,492
$4,481,940
$800,619

% of Net
Assets
0.360%
0.350%
0.348%
0.339%
0.314%
0.312%
0.274%
0.267%
0.267%
0.260%
0.255%
0.229%
0.228%
0.227%
0.213%
0.209%
0.207%
0.199%
0.198%
0.175%
0.168%
0.158%
0.157%
0.144%
0.144%
0.142%
0.132%
0.123%
0.108%
0.099%
0.095%
0.088%
0.052%
0.009%

Domestic Equities Total:

$6,372,516,114

73.9%

Actavis PLC
Shire PLC sponsored ADR
Mallinckrodt PLC
Teva Pharmaceutical Industries Ltd. sponsored ADR
Perrigo Co. PLC
Jazz Pharmaceuticals PLC
Endo Health Solutions, Inc.
Sanofi SA sponsored ADR
Valeant Pharmaceuticals International (Canada)
Actelion Ltd.
UCB SA
Dechra Pharmaceuticals PLC
Tornier NV
EBOS Group Ltd.

$638,376,800
$272,051,200
$257,478,000
$224,289,000
$213,964,800
$112,973,700
$79,332,000
$63,854,000
$42,949,733
$32,472,340
$27,531,058
$26,075,378
$25,500,000
$25,201,855

7.408%
3.157%
2.988%
2.603%
2.483%
1.311%
0.921%
0.741%
0.498%
0.377%
0.319%
0.303%
0.296%
0.292%

Security Name
PTC Therapeutics, Inc.
Zeltiq Aesthetics, Inc.
HealthStream, Inc.
Genmark Diagnostics, Inc.
ZS Pharma, Inc.
Acorda Therapeutics, Inc.
NPS Pharmaceuticals, Inc.
Pacira Pharmaceuticals, Inc.
Insmed, Inc.
Clovis Oncology, Inc.
Castlight Health, Inc.
Penumbra, Inc.
Dyax Corp.
TherapeuticsMD, Inc.
Achillion Pharmaceuticals, Inc.
Connecture, Inc.
Carriage Services, Inc.
Flexion Therapeutics, Inc.
BioCryst Pharmaceuticals, Inc.
TriVascular Technologies, Inc.
Omeros Corp.
Relypsa, Inc.
Nevro Corp.
Acceleron Pharma, Inc.
1Life Healthcare, Inc. Series G
Endologix, Inc.
Array BioPharma, Inc.
Genomic Health, Inc.
Derma Sciences, Inc.
Avalanche Biotechnologies, Inc.
Celldex Therapeutics, Inc.
Ariosa Diagnostics
Discovery Laboratories, Inc.
Castlight Health, Inc. Class B

Developed Markets

Fidelity Distributors Corporation

82 Devonshire Street
Not Part of Annual or Semiannual Report

Boston, MA 02109

Security Name
Meda AB (A Shares)
Amplifon SpA
United Drug PLC (United Kingdom)
Innate Pharma SA
Lumenis Ltd. Class B
Prothena Corp. PLC
Developed Markets Total:

Market Value
$22,224,218
$17,802,256
$16,705,698
$12,236,026
$10,797,358
$6,078,320

% of Net
Assets
0.258%
0.207%
0.194%
0.142%
0.125%
0.071%

$2,127,893,739

24.7%

$127,054,580
$545

1.474%
0.000%

$127,055,124

1.5%

Cash and Other Securities

Fidelity Cash Central Fund, 0.13%
Eur/Usd 1/2/2015 Spot Cc
Cash and Other Securities Total:

Fidelity Distributors Corporation

82 Devonshire Street
Not Part of Annual or Semiannual Report

Boston, MA 02109